Tag:

AI

Artificial Intelligence Presents an Underestimated Opportunity to Catalyze Digital Asset Adoption

The convergence of artificial intelligence and blockchain technology represents one of the most compelling, yet perhaps least understood, narratives poised to reshape the digital...

AI agents now deliver compliance alerts directly to crypto exchanges and banks without human review delays

The landscape of regulatory compliance in digital assets is undergoing a fundamental shift as artificial intelligence begins to replace traditional analyst workflows. Blockworks has...

Chinese AI companies reject US delegation over sanction fears

Amid escalating US China tech tensions, a delegation of American officials seeking dialogue with leading Chinese artificial intelligence firms was turned away this week....

Micron Secures Memory Supply to Stabilize NFT Infrastructure Amid AI Demand

As the NFT market expands, the need for reliable high‑performance memory has never been clearer. Micron Technology, a leading semiconductor supplier, is stepping up...

HIVE’s Paraguay GPUs Deliver H100 Level Performance and Drive a 22 Percent Stock Surge

HIVE Technologies has announced a breakthrough that could reshape the economics of artificial intelligence infrastructure. By deploying a network of high‑performance GPUs in Paraguay,...

Meme Coins Face Volatility as AI Spending Drives Market Sentiment

The surge in corporate artificial‑intelligence budgets, led by major tech firms, is reshaping risk appetite across the crypto space, and meme coins are feeling...

NEAR positions itself as the preferred settlement layer for high speed AI agent transactions

In the rapidly evolving world of decentralized finance, the NEAR Protocol has announced a bold strategy to pivot its platform into the high‑velocity arena...

Absci moves its AI‑driven cancer drug ABS‑201 into the first human trial phase

Absci Corporation, a pioneer in artificial intelligence-enabled drug discovery, has announced that its lead compound ABS‑201 has entered Phase I clinical trials. The milestone...